Pasar al contenido principal

TRANSMISION, MULTIPLICACION, TOXICIDAD Y DIANAS TERAPEUTICAS DE ENFERMEDADES PRIONICAS EN MODELOS CELULARES Y BIOENSAYOS

RTI2018-098711-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glycans are not necessary to maintain the pathobiological features of bovine spongiform encephalopathy

  • Otero, Alicia
  • Barrio, Tomás
  • Eraña, Hasier
  • Charco, Jorge M.
  • Betancor, Marina
  • Díaz-Domínguez, Carlos M.
  • Marín, Belén
  • Andréoletti, Olivier
  • Torres, Juan María
  • Kong, Qingzhong
  • Badiola, Juan J.
  • Bolea, Rosa
  • Castilla, Joaquín
22 Päg., The role of the glycosylation status of PrPC in the conversion to its pathological counterpart and on cross-species transmission of prion strains has been widely discussed. Here, we assessed the effect on strain characteristics of bovine spongiform encephalopathy (BSE) isolates with different transmission histories upon propagation on a model expressing a non-glycosylated human PrPC. Bovine, ovine and porcine-passaged BSE, and variant Creutzfeldt-Jakob disease (vCJD) isolates were used as seeds/inocula in both in vitro and in vivo propagation assays using the non-glycosylated human PrPC-expressing mouse model (TgNN6h). After protein misfolding cyclic amplification (PMCA), all isolates maintained the biochemical characteristics of BSE. On bioassay, all PMCA-propagated BSE prions were readily transmitted to TgNN6h mice, in agreement with our previous in vitro results. TgNN6h mice reproduced the characteristic neuropathological and biochemical hallmarks of BSE, suggesting that the absence of glycans did not alter the pathobiological features of BSE prions. Moreover, back-passage of TgNN6h-adapted BSE prions to BoTg110 mice recovered the full BSE phenotype, confirming that the glycosylation of human PrPC is not essential for the preservation of the human transmission barrier for BSE prions or for the maintenance of BSE strain properties., This work was supported financially by the following Spanish and European Interreg grants: RB, AGL2015-65560-R, MINECO Ministerio de Economía y Competitividad (Spanish Government) https://sede.mineco.gob.es/; RB, RTI2018-098711-B-I00, Ministerio de Ciencia, Innovación y Universidades (Spanish Government) https://www.ciencia.gob.es/; JC, RTI2018-098515-B-I00, Ministerio de Ciencia, Innovación y Universidades (Spanish Government) https://www.ciencia.gob.es/; JC, PID2021-122201OB-C21, Ministerio de Ciencia, Innovación y Universidades (Spanish Government) https://www.ciencia.gob.es/ partially supported by European Region Development Fund(ERDF) https://ec.europa.eu/regional_policy/en/funding/erdf/ ;RB & JJB, POCTEFA EFA148/16, European Region Development Fund (ERDF) https://ec.europa.eu/regional_policy/en/funding/erdf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

  • Toivonen, Janne Markus
  • Sánz-Rubio, David
  • López-Pérez, Óscar
  • Marín-Moreno, Alba
  • Bolea, Rosa
  • Osta, Rosario
  • Badiola, Juan J.
  • Zaragoza, P.
  • Espinosa, Juan Carlos
  • Torres, Juan María
  • Martín-Burriel, Inmaculada
20 Pág., MicroRNAs (miRNAs) may contribute to the development and pathology of many neurodegenerative diseases, including prion diseases. They are also promising biomarker candidates due to their stability in body fluids. We investigated miRNA alterations in a Tg501 mouse model of prion diseases that expresses a transgene encoding the goat prion protein (PRNP). Tg501 mice intracranially inoculated with mouse-adapted goat scrapie were compared with age-matched, mock inoculated controls in preclinical and clinical stages. Small RNA sequencing from the cervical spinal cord indicated that miR-223-3p, miR-151-3p, and miR-144-5p were dysregulated in scrapie-inoculated animals before the onset of symptoms. In clinical-stage animals, 23 significant miRNA alterations were found. These miRNAs were predicted to modify the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways including prion disease, extracellular matrix interactions, glutaminergic synapse, axon guidance, and transforming growth factor-beta signaling. MicroRNAs miR-146a-5p (up in cervical spinal cord) and miR-342-3p (down in cervical spinal cord, cerebellum and plasma), both indicated in neurodegenerative diseases earlier, were verified by quantitative real-time polymerase chain reaction (qRT-PCR). Minimal changes observed before the disease onset suggests that most miRNA alterations observed here are driven by advanced prion-associated pathology, possibly limiting their use as diagnostic markers. However, the results encourage further mechanistic studies on miRNA-regulated pathways involved in these neurodegenerative conditions., This research was partially funded by the Spanish Ministerio de Economía y Competitividad (AGL2015-67945-P to J.M.T. and I.M.-B.; AGL2016-78054-R [AEI/FEDER, UE] to J.-M.T. and J.-C.E.); Ministerio de Ciencia e Innovación (RTI2018-098711-B-I00); Instituto de Salud Carlos III (Grant PI17/00949) and Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa”; Instituto Nacional de Investigación y Tecnología Agraria y Agroalimentaria (fellowship INIA-FPI-SGIT-2015-02 to A.M.-M.); Spain-France-Andorra Cooperation Program (POCTEFA), co-funded by the European Regional Development Fund (ERDF) (EFA 148/16 REDPRION); the Government of Aragón (reference group A19-17R) co-financed with FEDER 2014-2020 “Construyendo Europa desde Aragón”, and Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas (CIBERNED)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Bambi and chga in prion diseases: neuropathological assessment and potential role as disease biomarkers

  • López-Pérez, Óscar
  • Bernal-Martín, Marcos
  • Hernaiz, Adelaida
  • Llorens, Franc
  • Betancor, Marina
  • Otero,Alicia
  • Toivonen, Janne Markus
  • Zaragoza, Pilar
  • Zerr, Inga
  • Badiola, Juan José
  • Bolea, Rosa
  • Martín-Burriel, Inmaculada.
Prion diseases affect both animals and humans. Research in the natural animal model of the disease could help in the understanding of neuropathological mechanisms and in the development of biomarkers for human pathologies. For this purpose, we studied the expression of 10 genes involved in prion propagation in vitro in the central nervous system of scrapie-infected sheep. Dysregulated genes (BAMBI and CHGA) were further analysed in a transgenic murine model (Tg338) of scrapie, and their protein distribution was determined using immunohistochemistry and Western blot. Their potential as biomarkers was finally assessed using enzyme-linked immunosorbent assay (ELISA) in cerebrospinal fluid (CSF) of scrapie sheep and Creutzfeldt-Jakob disease (CJD) patients. Protein BAMBI was upregulated in highly affected brain areas and CHGA was overexpressed along the brain in both models. Moreover, BAMBI and CHGA immunostaining scores strongly correlated with spongiosis and microgliosis in mice. Finally, levels of BAMBI were significantly higher in the CSF of clinical sheep and CJD patients. In addition to their potential as biomarkers, our work confirms the role of BAMBI and CHGA in prion neuropathology in vivo, but besides prion replication, they seem to be involved in the characteristic neuroinflammatory response associated to prion infection. Las enfermedades priónicas afectan tanto a los animales como a los humanos. La investigación en el modelo animal natural de la enfermedad podría ayudar en la comprensión de los mecanismos neuropatológicos y en el desarrollo de biomarcadores para patologías humanas. Para ello, estudiamos la expresión de 10 genes implicados en la propagación de priones in vitro en el sistema nervioso central de ovejas infectadas con scrapie. Genes desregulados ( BAMBI y CHGA) se analizaron más a fondo en un modelo murino transgénico (Tg338) de tembladera, y su distribución de proteínas se determinó mediante inmunohistoquímica y transferencia Western. Finalmente, se evaluó su potencial como biomarcadores utilizando un ensayo inmunoabsorbente ligado a enzimas (ELISA) en líquido cefalorraquídeo (LCR) de ovejas con tembladera y pacientes con enfermedad de Creutzfeldt-Jakob (ECJ). La proteína BAMBI se reguló positivamente en áreas cerebrales muy afectadas y CHGA se sobreexpresó a lo largo del cerebro en ambos modelos. Además, las puntuaciones de inmunotinción de BAMBI y CHGA se correlacionaron fuertemente con la espongiosis y la microgliosis en ratones. Finalmente, los niveles de BAMBI fueron significativamente más altos en el líquido cefalorraquídeo de ovejas clínicas y pacientes con ECJ. Además de su potencial como biomarcadores, nuestro trabajo confirma el papel de BAMBI y CHGA en la neuropatología priónica in vivo, pero además de la replicación priónica,
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

  • Toivonen, Janne M.
  • Sanz-Rubio, David
  • López-Pérez, Óscar
  • Marín-Moreno, Alba
  • Bolea, Rosa
  • Osta, Rosario
  • Badiola, Juan J.
  • Zaragoza, Pilar
  • Espinosa, Juan Carlos
  • Torres, Juan María
  • Martín-Burriel, Inmaculada
MicroRNAs (miRNAs) may contribute to the development and pathology of many neurodegenerative diseases, including prion diseases. They are also promising biomarker candidates due to their stability in body fluids. We investigated miRNA alterations in a Tg501 mouse model of prion diseases that expresses a transgene encoding the goat prion protein (PRNP). Tg501 mice intracranially inoculated with mouse-adapted goat scrapie were compared with age-matched, mock inoculated controls in preclinical and clinical stages. Small RNA sequencing from the cervical spinal cord indicated that miR-223-3p, miR-151-3p, and miR-144-5p were dysregulated in scrapie-inoculated animals before the onset of symptoms. In clinical-stage animals, 23 significant miRNA alterations were found. These miRNAs were predicted to modify the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways including prion disease, extracellular matrix interactions, glutaminergic synapse, axon guidance, and transforming growth factor-beta signaling. MicroRNAs miR-146a-5p (up in cervical spinal cord) and miR-342-3p (down in cervical spinal cord, cerebellum and plasma), both indicated in neurodegenerative diseases earlier, were verified by quantitative real-time polymerase chain reaction (qRT-PCR). Minimal changes observed before the disease onset suggests that most miRNA alterations observed here are driven by advanced prion-associated pathology, possibly limiting their use as diagnostic markers. However, the results encourage further mechanistic studies on miRNA-regulated pathways involved in these neurodegenerative conditions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Effect of scrapie prion infection in ovine bone marrow-derived mesenchymal stem cells and ovine mesenchymal stem cell-derived neurons

  • García-Mendívil, Laura
  • Mediano, Diego R.
  • Hernaiz, Adelaida
  • Sanz-Rubio, David
  • Vázquez, Francisco J.
  • Marín, Belén
  • López-Pérez, Óscar
  • Otero, Alicia
  • Badiola, Juan J.
  • Zaragoza, Pilar
  • Ordovás, Laura
  • Bolea, Rosa
  • Martín-Burriel, Inmaculada
Scrapie is a prion disease affecting sheep and goats and it is considered a prototype of transmissible spongiform encephalopathies (TSEs). Mesenchymal stem cells (MSCs) have been proposed as candidates for developing in vitro models of prion diseases. Murine MSCs are able to propagate prions after previous mouse-adaptation of prion strains and, although ovine MSCs express the cellular prion protein (PrPC), their susceptibility to prion infection has never been investigated. Here, we analyze the potential of ovine bone marrow-derived MSCs (oBM-MSCs), in growth and neurogenic conditions, to be infected by natural scrapie and propagate prion particles (PrPSc) in vitro, as well as the effect of this infection on cell viability and proliferation. Cultures were kept for 48–72 h in contact with homogenates of central nervous system (CNS) samples from scrapie or control sheep. In growth conditions, oBM-MSCs initially maintained detectable levels of PrPSc post-inoculation, as determined by Western blotting and ELISA. However, the PrPSc signal weakened and was lost over time. oBM-MSCs infected with scrapie displayed lower cell doubling and higher doubling times than those infected with control inocula. On the other hand, in neurogenic conditions, oBM-MSCs not only maintained detectable levels of PrPSc post-inoculation, as determined by ELISA, but this PrPSc signal also increased progressively over time. Finally, inoculation with CNS extracts seems to induce the proliferation of oBM-MSCs in both growth and neurogenic conditions. Our results suggest that oBM-MSCs respond to prion infection by decreasing their proliferation capacity and thus might not be permissive to prion replication, whereas ovine MSC-derived neuron-like cells seem to maintain and replicate PrPSc.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cerebrospinal fluid and plasma small extracellular vesicles and mirnas as biomarkers for prion diseases

  • López-Pérez, Óscar
  • Sanz-Rubio, David
  • Hernaiz, Adelaida
  • Betancor, Marina
  • Otero, Alicia
  • Castilla, Joaquín
  • Andréoletti, Olivier
  • Badiola, Juan José
  • Zaragoza, Pilar
  • Bolea, Rosa
  • Toivonen, Janne
  • Martín-Burriel, Inmaculada
Diagnosis of transmissible spongiform encephalopathies (TSEs), or prion diseases, is based on the detection of proteinase K (PK)-resistant PrPSc in post-mortem tissues as indication of infection and disease. Since PrPSc detection is not considered a reliable method for in vivo diagnosis in most TSEs, it is of crucial importance to identify an alternative source of biomarkers to provide useful alternatives for current diagnostic methodology. Ovine scrapie is the prototype of TSEs and has been known for a long time. Using this natural model of TSE, we investigated the presence of PrPSc in exosomes derived from plasma and cerebrospinal fluid (CSF) by protein misfolding cyclic amplification (PMCA) and the levels of candidate microRNAs (miRNAs) by quantitative PCR (qPCR). Significant scrapie-associated increase was found for miR-21-5p in plasma-derived but not in CSF-derived exosomes. However, miR-342-3p, miR-146a-5p, miR-128-3p and miR-21-5p displayed higher levels in total CSF from scrapie-infected sheep. The analysis of overexpressed miRNAs in this biofluid, together with plasma exosomal miR-21-5p, could help in scrapie diagnosis once the presence of the disease is suspected. In addition, we found the presence of PrPSc in most CSF-derived exosomes from clinically affected sheep, which may facilitate in vivo diagnosis of prion diseases, at least during the clinical stage.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Genome-Wide Methylation Profiling in the Thalamus of Scrapie Sheep

  • Hernaiz Martorell, A.
  • Sanz Fernández, A.
  • Sentre, S.
  • Ranera, B.
  • Lopez-Pérez, O.
  • Zaragoza Fernández, P.
  • Badiola Díez, J.J.
  • Filali, H.
  • Bolea Bailo, R.
  • Toivonen, J.M
  • Martín-Burriel, I.
Scrapie is a neurodegenerative disorder belonging to the group of transmissible spongiform encephalopathy (TSE). Scrapie occurs in sheep and goats, which are considered good natural animal models of these TSE. Changes in DNA methylation occur in the central nervous system (CNS) of patients suffering from prion-like neurodegenerative diseases, such as Alzheimer''s disease. Nevertheless, potential DNA methylation alterations have not yet been investigated in the CNS of any prion disease model or naturally infected cases, neither in humans nor in animals. Genome-wide DNA methylation patterns were studied in the thalamus obtained from sheep naturally infected with scrapie at a clinical stage (n = 4) and from controls (n = 4) by performing a whole-genome bisulfite sequencing (WGBS) analysis. Ewes carried the scrapie-susceptible ARQ/ARQ PRNP genotype and were sacrificed at a similar age (4–6 years). Although the average genomic methylation levels were similar between the control and the scrapie animals, we identified 8, 907 significant differentially methylated regions (DMRs) and 39 promoters (DMPs). Gene Ontology analysis revealed that hypomethylated DMRs were enriched in genes involved in transmembrane transport and cell adhesion, whereas hypermethylated DMRs were related to intracellular signal transduction genes. Moreover, genes highly expressed in specific types of CNS cells and those previously described to be differentially expressed in scrapie brains contained DMRs. Finally, a quantitative PCR (qPCR) validation indicated differences in the expression of five genes (PCDH19, SNCG, WDR45B, PEX1, and CABIN1) that matched the methylation changes observed in the genomic study. Altogether, these results suggest a potential regulatory role of DNA methylation in prion neuropathology. Copyright © 2022 Hernaiz, Sanz, Sentre, Ranera, Lopez-Pérez, Zaragoza, Badiola, Filali, Bolea, Toivonen and Martín-Burriel.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie

  • Betancor, M.
  • Pérez-Lázaro, S.
  • Otero, A.
  • Marín, B.
  • Martín-Burriel , I.
  • Blennow, K.
  • Badiola, J.J.
  • Zetterberg, H.
  • Bolea, R.
Prion diseases are diagnosed in the symptomatic stage, when the neuronal damage is spread throughout the central nervous system (CNS). The assessment of biological features that allow the detection of asymptomatic cases is needed, and, in this context, scrapie, where pre-symptomatic infected animals can be detected through rectal biopsy, becomes a good study model. Neurogranin (Ng) and neurofilament light chain (NfL) are proteins that reflect synaptic and axonal damage and have been studied as cerebrospinal fluid (CSF) biomarkers in different neurodegenerative disorders. In this study, we evaluated Ng and NfL both at the protein and transcript levels in the CNS of preclinical and clinical scrapie-affected sheep compared with healthy controls and assessed their levels in ovine CSF. The correlation between these proteins and the main neuropathological events in prion diseases, PrPSc deposition and spongiosis, was also assessed. The results show a decrease in Ng and NfL at the protein and gene expression levels as the disease progresses, and significant changes between the control and preclinical animals. On the contrary, the CSF levels of NfL increased throughout the progression of the disease. Negative correlations between neuropathological markers of prion disease and the concentration of the studied proteins were also found. Although further research is needed, these results suggest that Ng and NfL could act as biomarkers for neurodegeneration onset and intensity in preclinical cases of scrapie.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Glycans are not necessary to maintain the pathobiological features of bovine spongiform encephalopathy

  • Otero, Alicia
  • Barrio, Tomás
  • Eraña, Hasier
  • Charco, Jorge M.
  • Betancor, Marina
  • Díaz-Domínguez, Carlos M.
  • Marín, Belén
  • Andréoletti, Olivier
  • Torres, Juan M.
  • Kong, Qingzhong
  • Badiola, Juan J.
  • Bolea, Rosa
  • Castilla, Joaquín
The role of the glycosylation status of PrPC in the conversion to its pathological counterpart and on cross-species transmission of prion strains has been widely discussed. Here, we assessed the effect on strain characteristics of bovine spongiform encephalopathy (BSE) isolates with different transmission histories upon propagation on a model expressing a non-glycosylated human PrPC. Bovine, ovine and porcine-passaged BSE, and variant Creutzfeldt-Jakob disease (vCJD) isolates were used as seeds/inocula in both in vitro and in vivo propagation assays using the non-glycosylated human PrPC-expressing mouse model (TgNN6h). After protein misfolding cyclic amplification (PMCA), all isolates maintained the biochemical characteristics of BSE. On bioassay, all PMCA-propagated BSE prions were readily transmitted to TgNN6h mice, in agreement with our previous in vitro results. TgNN6h mice reproduced the characteristic neuropathological and biochemical hallmarks of BSE, suggesting that the absence of glycans did not alter the pathobiological features of BSE prions. Moreover, back-passage of TgNN6h-adapted BSE prions to BoTg110 mice recovered the full BSE phenotype, confirming that the glycosylation of human PrPC is not essential for the preservation of the human transmission barrier for BSE prions or for the maintenance of BSE strain properties.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

RNA-sequencing transcriptomic analysis of scrapie-exposed ovine mesenchymal stem cells

  • Hernaiz, Adelaida
  • Marín, Belén
  • Vázquez, Francisco J.
  • Badiola, Juan J.
  • Zaragoza, Pilar
  • Bolea, Rosa
  • Martín-Burriel, Inmaculada
In neurodegenerative diseases, including prion diseases, cellular models arise as useful tools to study the pathogenic mechanisms occurring in these diseases and to assess the efficacy of potential therapeutic compounds. In the present study, a RNA-sequencing analysis of bone marrow-derived ovine mesenchymal stem cells (oBM-MSCs) exposed to scrapie brain homogenate was performed to try to unravel genes and pathways potentially involved in prion diseases and MSC response mechanisms to prions. The oBM-MSCs were cultured in three different conditions (inoculated with brain homogenate of scrapie-infected sheep, with brain homogenate of healthy sheep and in standard growth conditions without inoculum) that were analysed at two exposure times: 2 and 4 days post-inoculation (dpi). Differentially expressed genes (DEGs) in scrapie-treated oBM-MSCs were found in the two exposure times finding the higher number at 2 dpi, which coincided with the inoculum removal time. Pathways enriched in DEGs were related to biological functions involved in prion toxicity and MSC response to the inflammatory environment of scrapie brain homogenate. Moreover, RNA-sequencing analysis was validated amplifying by RT-qPCR a set of 11 DEGs with functions related with prion propagation and its associated toxicity. Seven of these genes displayed significant expression changes in scrapie-treated cells. These results contribute to the knowledge of the molecular mechanisms behind the early toxicity observed in these cells after prion exposure and to elucidate the response of MSCs to neuroinflammation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry

  • Pérez-Lázaro, Sonia
  • Barrio, Tomás
  • Bravo, Susana B.
  • Sevilla, Eloisa
  • Otero, Alicia
  • Chantada-Vázquez, María del Pilar
  • Martín-Burriel, Inmaculada
  • Requena, Jesús R.
  • Badiola, Juan J.
  • Bolea, Rosa
Current diagnostic methods for prion diseases only work in late stages of the disease when neurodegeneration is irreversible. Therefore, biomarkers that can detect the disease before the onset of clinical symptoms are necessary. High-throughput discovery proteomics is of great interest in the search for such molecules. Here we used mass spectrometry to analyse the cerebrospinal fluid proteome in an animal prion disease: preclinical and clinical sheep affected with natural scrapie, and healthy sheep. Interestingly, we found 46 proteins in the preclinical stage that were significantly altered (p < 0.01) compared to healthy sheep, mainly associated with biological processes such as stress and inflammatory responses. Five of them were selected for validation by enzyme-like immunosorbent assay: synaptotagmin binding, cytoplasmic RNA interacting protein (SYNCRIP), involved in nucleic acid metabolism; phospholipase D3 (PLD3) and cathepsin D (CTSD), both related to lysosomal apoptosis; complement component 4 (C4), an element of the classical immune response; and osteopontin (SPP1), a proinflammatory cytokine. These proteins significantly increased in the preclinical stage and maintained their levels in the clinical phase, except for CTSD, whose concentration returned to basal levels in the clinical group. Further research is ongoing to explore their potential as preclinical biomarkers of prion diseases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Susceptibility of ovine bone marrow-derived mesenchymal stem cell spheroids to scrapie prion infection

  • Hernaiz, Adelaida
  • Cobeta, Paula
  • Marín, Belén
  • Vázquez, Francisco José
  • Badiola, Juan José
  • Zaragoza, Pilar
  • Bolea, Rosa
  • Martín-Burriel, Inmaculada
In neurodegenerative diseases, including prion diseases, cellular in vitro models appear as fundamental tools for the study of pathogenic mechanisms and potential therapeutic compounds. Two-dimensional (2D) monolayer cell culture systems are the most used cell-based assays, but these platforms are not able to reproduce the microenvironment of in vivo cells. This limitation can be surpassed using three-dimensional (3D) culture systems such as spheroids that more effectively mimic in vivo cell interactions. Herein, we evaluated the effect of scrapie prion infection in monolayer-cultured ovine bone marrow-derived mesenchymal stem cells (oBM-MSCs) and oBM-MSC-derived spheroids in growth and neurogenic conditions, analyzing their cell viability and their ability to maintain prion infection. An MTT assay was performed in oBM-MSCs and spheroids subjected to three conditions: inoculated with brain homogenate from scrapie-infected sheep, inoculated with brain homogenate from healthy sheep, and non-inoculated controls. The 3D conditions improved the cell viability in most cases, although in scrapie-infected spheroids in growth conditions, a decrease in cell viability was observed. The levels of pathological prion protein (PrPSc) in scrapie-infected oBM-MSCs and spheroids were measured by ELISA. In neurogenic conditions, monolayer cells and spheroids maintained the levels of PrPSc over time. In growth conditions, however, oBM-MSCs showed decreasing levels of PrPSc throughout time, whereas spheroids were able to maintain stable PrPSc levels. The presence of PrPSc in spheroids was also confirmed by immunocytochemistry. Altogether, these results show that a 3D culture microenvironment improves the permissiveness of oBM-MSCs to scrapie infection in growth conditions and maintains the infection ability in neurogenic conditions, making this model of potential use for prion studies.